References
  1. Presepsin (sCD14-ST), an innate immune response marker in sepsis. Chenevier-Gobeaux C, Borderie D, Weiss N, Mallet-Coste T, Claessens YE, Clinica Chimica Acta. 450 (2015):97-103
  2. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome.
    Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S, J Infect Chemother. 17 (2011):764-9
  3. Diagnostic and prognostic value of Presepsin (soluble CD14 subtype) in emergency patients with early sepsis using the new assay PATHFAST Presepsin. Spanuth E, Ebelt H, Ivandic B, Werdan K,
    21st International Congress of Clinical Chemistry and Laboratory Medicine, IFCC-World Lab-EuroMedLab, Berlin, 15-19 May 2011
  4. qSOFA (quick SOFA) score, presepsin and procalcitonin for severity assesment in initial sepsis. Spanuth E, Ebelt H, Ivandic B, Thomae R, Werdan K, ISICEM 2017 – 37th International symposium on Intensive Care and Emergency Medicine, Brussels, March 21-24, 2017
  5. Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial. Masson S, Caironi P, Fanizza C, Thomae R, Bernasconi R, Noto A, Oggioni R, Pasetti GS, Romero M, Tognoni G, Latini R, Gattinoni L, Intensive Care Med. 41 (2015):12-20
  6. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial. Masson S, Caironi P, Spanuth E, Thomae R, Panigada M, Sangiorgi G, Fumagalli R, Mauri T, Isgrò S, Fanizza C, Romero M, Tognoni G, Latini R, Gattinoni L; ALBIOS Study Investigators. Crit Care. 18 (2014) R6
  7. Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates. Pugni L, Pietrasanta C, Milani S, Vener C, Ronchi A, Falbo M, Arghittu M, Mosca F; PLoS One. (2015)
  8. Presepsin for the detection of late-onset sepsis in preterm newborns. Poggi C, Bianconi T, Gozzini E, Generoso M, Dani C, Pediatrics. 135 (2015):68-75
  9. Presepsin (sCD14-ST) Is a Novel Marker for Risk Stratification in Cardiac Surgery Patients. Bomberg H, Klingele M, Wagenpfeil S, Spanuth E, Volk T, Sessler DI, Schäfers HJ, Groesdonk HV, Anesthesiology. 126 (2017):631-42
  10. Utility of presepsin (sCD14-ST) as a diagnostic and prognostic marker of sepsis in the emergency department. Carpio R, Zapata J, Spanuth E, Hess G, Clin Chim Acta. 450 (2015):169-75
  11. Early elevation of plasma soluble CD14 subtype, a novel biomarker for sepsis, in a rabbit cecal ligation and puncture model. Nakamura M, Takeuchi T, Naito K, Shirakawa K, Hosaka Y, Yamasaki F, Furusako S, Crit Care. 12 (2008) Suppl. 12: 194

 

References Neonatal Sepsis

  1. Goldstein B, Giroir B, Randolph A, and the International Concensus Conference on Pediatric Sepsis: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6: 2-8
  2. Stoll BJ, Hansen NI et al.: National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004; 292: 2357-65
  3. Weston EJ, Pondo T et al.: The burden of invasive early-onset neonatal sepsis in the United States, 2005–2008. Pediatr Infect Dis J 2011, 30(11): 937-41
  4. Hedegaard SS, Wisborg K et al.: Diagnostic utility of biomarkers for neonatal sepsis – a systematic review. Scand J Infect Dis. 2014; 18: 1-8
  5. Hao L, Wang N. et al.: Changes in plasma thrombomodulin and D-dimer levels and their clinical significance in neonates with sepsis. CJCP, 2013, 15(10): 841-44
  6. Chenevier-Gobeaux C, Borderie DE et al.: Presepsin (sCD14), an innate immune response marker in sepsis. Clinica Chimica Acta. 450 (2015): 97-103
  7. Ting Xiao, Li-Ping Chen et al.: The clinical significance of sCD14-ST for blood biomarker in neonatal hematosepsis. Medicine. 2017 (18): e6823
  8. Poggi C, Bianconi T et al.: Presepsin for the detection of late-onset sepsis in preterm newborns. Pediatrics. 2015;135: 68-75
  9. Montaldo P, Rosso R: Presepsin for the detection of early-onset sepsis in preterm newborns. Pediatr Res 2017 (2): 329-34
  10. Bellos I, Fitrou G et al.: The diagnostic accuracy of presepsin in neonatal sepsis: a meta-analysis. European Journal of Pediatrics 2018; 177: 625-32
  11. Levy E, Xanthou G et al.: Distinct roles of TLR4 and CD14 in LPS-induced inflammatory responses of neonates. Pediatr Res 2009 (2): 179-84
  12. Pugni L, Pietrasanta C et al.: Presepsin (Soluble CD14 Subtype): Reference ranges of a new sepsis marker in term and preterm neonates. PLOS one 2015: 1-11
  13. Mussap M, Puxeddu E et al.: Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS. Clin Chim Acta 2015 451 (Pt A): 65-70.
  14. Tabl HA, Abed NT (2016): Diagnostic value of presepsin in neonatal sepsis. Egypt J Immunol 23(2): 29-37
  15. Ozdemir AA, Elgormus Y: Diagnostic value of presepsin in detection of early-onset neonatal sepsis. Am J Perinatol 2017 34(6): 550-56
  16. Topcuoglu S, Arslanbuga C et al.: Role of presepsin in the diagnosis of late-onset neonatal sepsis in preterm infants. J Matern Fetal Neonatal Med 2016 29(11): 1834-39
  17. Sabry J, Elfeky O et al.: Presepsin as an early reliable diagnostic and prognostic marker of neonatal sepsis. Int J Adv Res 2016 4(6): 1538-49
  18. Osman A, Goudah A et al.: Presepsin as a novel diagnostic marker in neonatal septicemia. Egypt J Med Microbiol 2015 24(3):21-26
  19. Motalib T, Khalaf F et al.: Soluble CD14-subtype (prespsin) and hepcidin as diagnostic and prognostic markers in early onset neonatal sepsis. Egypt J Med Microbiol 2015 24(3)
  20. Miyosawa Y, Akazawa Yet al.: Presepsin as a predictor of positive blood culture among newborns suspected sepsis. Pediatr Res 2018 (2): 157-61
  21. Astrawinata D et al.: The role of Presepsin, C-reactive protein and procalcitonin as a marker of therapy response and prognosis for late onset neonatal sepsis in preterm neonates. J Med Sci Clin Res 2017 5(8)
  22. Mostafa R, Kholouss S et al.: Detection of presepsin and surface CD14 as a biomarker for early diagnosis of neonatal sepsis. 2015 J Am Sci 1111(1010): 104-16
  23. Ruan L, Chen GY et al.: The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review. Critical Care 2018 1 (116)